Table 1.
Donor information
| Donor ID | Donor reference | Sex | Age (years) | Duration of diabetes (years) | Islet-AAbs* | C-peptide (ng/mL) | HLA-DRB1 | HLA-A | HLA-B | HLA-C |
| T1D-1 | nPOD 69 | F | 6 | 3 | IAA | <0.05 | 04:01/07:01 | 02:01/26:01 | 35:01/50:01 | 04:01/06:02 |
| T1D-2 | nPOD 6323 | F | 22 | 6 | GADA IA2A | <0.02 | 03:01/04:02 | 01:01/25:01 | 08:01/18:01 | 07:01/12:03 |
| T1D-3 | nPOD 6342 | F | 14 | 2 | IAA IA-2A | 0.26 | 01:01/04:01 | 02:01/68:01 | 40:01 | 03:04 |
| T1D-4 | nPOD 6367 | M | 24 | 2 | None | 0.39 | 04:01/07:01 | 02:01/29:02 | 18:01/44:03 | 07:01/16:01 |
| T1D-5 | nPOD 6414 | M | 23 | 0.4 | IAA GADA ZnT8A | 0.16 | 03:01/09:01 | 01:01/23:01 | 07:02/08:01 | 07:01/07:02 |
| T1D-6 | nPOD 6472 | F | 10 | 4 | IAA | 0.02 | 03:01/04:04 | 02:01/32:01 | 08:01/18:01 | 05:01/07:01 |
| T1D-7 | VUMC/ Pittsburgh | F | 28 | 15 | IAA | 0.03 | 08:04/09:01 | 02:05/23:01 | 35:01/41:02 | 04:01/17:01 |
| ND-1 | IIDP 9657 | F | 34 | No diabetes | Not tested | Not tested | 03:01/15:01 | 01:01/02:01 | 08:01/44:02 | 05:01/07:01 |
| ND-2 | IIDP 1726 | M | 21 | No diabetes | Not tested | Not tested | 07:01 | 02:01/29:02 | 27:05/44:03 | 02:02/16:01 |
| ND-3 | R300 | F | 30 | No diabetes | Not tested | Not tested | 03:01 | 01:01/30:02 | 08:01/18:01 | 05:01/07:01 |
| ND-4 | R301 | M | 18 | No diabetes | Not tested | Not tested | 11:01/13:02 | 02:01 | 14:02/49:01 | 07:04/08:02 |
| ND-5 | IIDP 5642 | M | 30 | No diabetes | Not tested | Not tested | 10:01/13:02 | 02:01/24:02 | 40:01/45:01 | 03:04/16:01 |
| ND-6 | IIDP 7400 | F | 30 | No diabetes | Not tested | Not tested | 03:01/15:01 | 03:01/30:02 | 07:02/18:01 | 05:01/07:02 |
| ND-7 | R283 | M | 22 | No diabetes | Not tested | Not tested | 1,13 | 1,2 | 51 (Bw4) | Cw15 |
*
Islet-autoantibodies: IAA = insulin antibodies; GADA = glutamic acid decarboxylase antibodies; IA-2A = insulinoma antigen-2 antibodies; ZnT8A = zinc transporter 8 antibodies